Old Wegmaster from Yahoo Board
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can someone explain how they are coming out of bankruptcy and reverse merger? Thanks
I bought today. I wonder if with Covid 19, some of that old 20 mil dollar inventory has some value to create some take out food sustainable packaging. Resins don't go bad as far as I know.
They should be using that facility for some type of COVID 19 service. I own this stock CREX, they do digital signage. They found a COVID product idea and jumped from .70 to $4 in one day....
ADXS should consider an angle...
https://cri.com
[img][/img]YOUR PEOPLE AND PHYSICAL SPACE WITH THE THERMAL MIRROR DEVICE & AI PLATFORM
Safety Made Simple
No-contact remote forehead temperature inspection
Multi-point temperature: Stop, Scan, View and Log instantly, with output +/- 1 second
Reliable accuracy +/- 0.5°C | +/- 0.9°F
Works by facial detection with or without mask; with or without photos through facial recognition
If individuals exceed temperature limits, notification will happen, delivering via email or SMS
Works immediately after the device is powered on – no calibration needed
Anyone guess what revenue might come from this thermal temp mirror?
Average volume 14, 000, Today's volume 66 million...Kicking myself I did not buy more, but I have owned this thing for like a decade... I am still down from all the dilution over the years...
I wonder...This volume is beyond.... What is the news?
So here is CREX profitable with no interest. Dilution killed my holdings when it was Wireless Ronin....not worth selling....
From when things actually looked good....2016
https://www.pharmaceuticalprocessingworld.com/advaxis-unveils-manufacturing-facility-laboratory-for-novel-immuno-oncology-therapeutics/
Somebody can confirm that number. They had $$ when they built it.
Hey, I think the shorts are gone. They should take that plant and put it to work to fight this pandemic.
Besides doing the right thing. I could help the company.
50 million dollar manufacturing facility....I agree. How can ADXS be of service. Duty calls...I am not the expert, just common sense.
Probably true and shame on him. He seems to be a savage.
Best article in quite awhile. Basically banking on Merck....if they come through...game changer. IF...
I am afraid to learn how much equity capital has been lost...
Frigin ADXS should take that 50 mill manufacturing facility and do something for Corona Virus. All hands on deck....come on...
People talking without speaking
People hearing without listening
People writing songs that voices never share
Silence like a cancer grows....
Let's hope this silence is part of ADXS HOT stopping cancer from growing??
Tomorrow looks scary for the market....
Did he present? Anything interesting?
Anson Funds Management LP - Anyone know what this 13d filing means? Does not show any shares.
Hopefully they don't dump after doubling their money. I remember when this board gave us insightful feedback on such new. Hard to believe we did not get a bump up...I guess old news for insiders.
Nano cap Advaxis (ADXS -1.9%) announces updated survival data from a Phase 1/2 clinical trial, KEYNOTE-046, evaluating ADXS-PSA, as monotherapy and in combination with Merck's Keytruda (pembrolizumab), in patients with metastatic castration-resistant prostate cancer. The results were presented at the ASCO GU Cancers Symposium in San Francisco.
Median overall survival (OS) was 33.7 months for patients receiving the combo (n=37).
Median OS was 16.0 months for patients who previously received chemo agent docetaxel (n=20).
Median OS was 16.4 months for patients with prior visceral metastases (n=11) (10 had prior docetaxel).
72.4% (n=21/29) of evaluable patients showed stable cancer.
38% of patients experienced PSA declines.
In April 2019, the company reported median OS of 21.1 months for the combo.
Ever since Aratana Therapeutics became a wholly owned subsidiary of Elanco Animal Health, it seems quiet.....
For some reason, they are not giving attention that they should.... no news forever.... I think they are snoozing...
https://www.aratana.com/?s=at-014
Different subject, I am talking the about Tutes, Equity firms, CEOs, Hedge funds etc. Big short players, companies that take opposing positions etc. I am not the expert. But, the big money takes short positions on a company that is at their mercy. I am not expert, but we have seen "legal manipulating" that is controlled. Retail guys like us can't do that.
His job: Maximize shareholder value HIs results: We are down 99 plus percent. Compensation Due: 0
If you get the big bucks, you take the big risk. Rewarding no results. He has not raised a penny except through dilution. We need a real industry leader.
Sounds illegal to me. Call the SEC.
Nobody. Unless, like James says they bought in .20s....LT most are down 99% from dilution R/S's.
But we are still here....GO ADXS! GO HOT! Come on Merck!
This sucks. James S. No positive spin here....we needed money from somewhere besides dilution. The only thing I see that says something, is that there are buyers for this offering.
A small Hallelujah....
I hope you are right. Us LT holders, have had enough crow to eat over the years for some serious indigestion. I just wish I had more guts to buy more than I did at .28.... No 20/20 vision on ADXS.
So sorry...hang in there....not alone...Shorts got us before...market manipulation is evil, they don't care about science LT....
So how big is this news on Phase 1? Who is coming off the bench?
There are lots of us in that boat....You never know...More news please.
I did have the guts to buy small amount at .28. My wife was not too happy about that at the time....
Glad a bought a small amount at .28....I was actually nervous
Bring it on!
I wonder if below has something to do with the rise...HOT is HOT from 12/19:
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical study of ADXS-504, the Company’s ADXS-HOT drug candidate for prostate cancer.
And the market is down...strong!
Us retailers will get it last....Day 2 over a buck! Yeah! and looks like breaking through $1.00 resistance...
10 days above a buck...please something is cooking...I guess us guys on the message board will find out eventually
What a day....I looked early and we were at .93, then boom looked like a shorts panic... instead of being up a dime, we are down a nickel.... I wonder what short position is now... How about some New Years big news...give us a gift Ken....
Really? ?? Shorts got us again today....
James, Could happen...I like the positive vibe.... I had that before the last 2 RS also.... now I am broke, but I never sold a share and bought 6000 shares at .28
James, your factual optimism is appreciated. Big news is the only way to beat the manipulators....
Same old....we need BIG news to deal w/ Shorts until then they just keep feasting....
DITTO- Still amazed they can’t secure a single deal worth anything after all these years